Hosted on MSN3mon
Amneal gets FDA approval for generic Byetta, resubmits DHE NDAAmneal Pharmaceuticals (NASDAQ:AMRX) has received FDA approval for its generic version of the GLP-1 agonist diabetes drug Byetta and resubmitted its New Drug Application for a prefilled syringe ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback